Logo image of ACRV

ACRIVON THERAPEUTICS INC (ACRV) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:ACRV - US0048901096 - Common Stock

2.05 USD
+0.02 (+0.99%)
Last: 1/23/2026, 8:00:00 PM
2.03 USD
-0.02 (-0.98%)
After Hours: 1/23/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACRV revenue by date.ACRV revenue by date.
N/AN/A
805.34%		N/A
691.78%		N/A
321.81%		N/A
132.56%		N/A
57.38%		N/A
35.59%		N/A
41.31%		N/A
23.16%
EBITDA
YoY % growth
ACRV ebitda by date.ACRV ebitda by date.
-3.16M-16.14M
-410.76%		-32.3M
-100.12%		-66.567M
-106.09%		-88.193M
-32.49%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACRV ebit by date.ACRV ebit by date.
-3.17M-16.18M
-410.41%		-32.66M
-101.85%		-67.103M
-105.46%		-89.199M
-32.93%		N/A
6.56%		N/A
-17.29%		N/A
-33.96%		N/A
-9.61%		N/A
21.80%		N/A
54.93%		N/A
208.51%		N/A
130.70%		N/A
44.52%
Operating Margin
ACRV operating margin by date.ACRV operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACRV eps by date.ACRV eps by date.
N/AN/AN/A-2.73
60.91%		-2.44
10.62%		N/A
16.05%		N/A
5.32%		N/A
-4.74%		N/A
3.72%		N/A
20.08%		N/A
57.75%		N/A
172.59%		N/A
270.21%		N/A
58.05%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.48
20.74%		-0.50
1.11%		-0.53
4.17%		-0.52
-11.61%		-0.58
-22.25%
Revenue
Q2Q % growth		169.024K
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-21.551M
13.64%		-22.503M
-3.88%		-23.661M
-4.47%		-25.058M
-27.28%		-27.929M
-29.59%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.47
20.34%		-0.600.1321.90%
Q2 2025
Q2Q % growth		 -0.55
-5.77%		-0.600.058.02%
Q1 2025
Q2Q % growth		 -0.51
30.14%		-0.660.1522.15%
Q4 2024
Q2Q % growth		 -0.60
30.23%		-0.680.0811.91%
Q3 2024
Q2Q % growth		 -0.59
10.61%		-0.590.00-0.13%
Q2 2024
Q2Q % growth		 -0.52
17.46%		-0.610.0915.33%
Q1 2024
Q2Q % growth		 -0.73
-25.86%		-0.860.1315.28%
Q4 2023
Q2Q % growth		 -0.86
-7.50%		-0.74-0.12-15.99%
Q3 2023
Q2Q % growth		 -0.66 -0.720.068.67%
Q2 2023
Q2Q % growth		 -0.63 -0.660.034.77%
Q1 2023
Q2Q % growth		 -0.58 -0.610.035.27%
Q4 2022
Q2Q % growth		 -0.80 -1.120.3228.37%
ACRV Yearly EPS VS EstimatesACRV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ACRV Yearly Revenue VS EstimatesACRV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.14% 14.19% 0.64% 9.21%
Revenue-14.29% 14.28% -12.5% 0%